UNSPSC 51281719: Lenampicillin hydrochloride

This classification denotes a penicillin antibiotic C21H23N3O7S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6U90E2WB40, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((2r)-2-amino-2-phenylacetyl)amino)-3,3-dimethyl-7-oxo-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester, hydrochloride (1:1), (2s,5r,6r)-, but more generally known as lenampicillin hydrochloride, which bears US NIH Compound Identifier 6917773.

UNSPSC 51281719 Lenampicillin hydrochloride is a Commodity code for a specific antibiotic pharmaceutical product. State and local governments procure this drug through piggyback contracts and cooperative purchasing vehicles tied to existing statewide or regional pharmaceutical supply agreements. The code sees activity from state health departments and county public health systems sourcing branded and generic pharmaceutical inventory to support clinical operations, emergency preparedness, and community health programs. Recent solicitations show state and local buyers using competitive bidding processes — including invitation-for-bid (IFB) and cooperative purchasing piggyback mechanisms — to secure pharmaceutical warehouse orders with multi-year contract terms and quarterly or regular delivery schedules.

Activity under this code concentrates in Illinois and Florida, based on recent postings. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse order through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 under IFB 26482DPHPREPDB53392, covering a 12-month initial term with two optional renewal years. Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking annual procurement of naloxone and drug deactivation systems through quarterly deliveries, with responses due July 26, 2023. These opportunities reflect demand from state departments and county health systems for reliable supplier relationships under fixed-fee, multi-year arrangements with built-in renewal options and documented compliance requirements including drug-free workplace certification and E-Verify.